Sandbox vidit: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree | | | | | | | | | |,|-| A01 |-| A02 | | | |A01= |A02= }}
{{familytree | | | | | | | | | | | | | | F01 | | | | |F01=Stabilization phase (1-2 months): <br> Transition when patient has:
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }}
:* No withdrawal symptoms <br>
{{familytree | | | | | | | | | |)|-| B01 |-| B02 | | | |B01= |B02= }}
:* Minimal or no side effects <br>
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }}
:* No uncontrollable craving for opioid agonists <br> Begin with buprenorphine/naloxone combination, increasing dose by 2/0.5-4/1 mg per week till stabilization is achieved, most stabilizing at 16/4-24/6 mg} <br> As patient stabilizes, transition to alternate day or every third day regimen by doubling and tripling daily doses respectively}}
{{familytree | | | | | | C01 |-|+|-| C02 |-| C03 | | | |C01= |C02= |C03= }}
{{familytree | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | |)|-| D01 |-| D02 | | | |D01= |D02= }}
{{familytree | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | |`|-| E01 |-| E02 | | | |E01= |E02= }}
{{familytree | | | | | | | | | | | | | | | | | | | | | }}
{{familytree/end}}
{{familytree/end}}

Revision as of 21:06, 6 February 2014

 
 
 
 
 
 
 
 
 
 
 
 
 
Stabilization phase (1-2 months):
Transition when patient has:
  • No withdrawal symptoms
  • Minimal or no side effects
  • No uncontrollable craving for opioid agonists
    Begin with buprenorphine/naloxone combination, increasing dose by 2/0.5-4/1 mg per week till stabilization is achieved, most stabilizing at 16/4-24/6 mg}
    As patient stabilizes, transition to alternate day or every third day regimen by doubling and tripling daily doses respectively